Research graph
References from Can Axillary Positivity Be Predicted Using Hemogram Parameters in Patients with Breast Cancer at the Time of Diagnosis?. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer incidence and mortality projections in the UK until 2035
10.1038/bjc.2016.304 · 2016 · External reference
Cancer statistics, 2019
2019 · External reference
Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study
10.1016/s2214-109x(20)30215-1 · 2020 · External reference
Complications of axillary lymph node dissection in treatment of early breast cancer: A comparison of MRM and BCS
10.1007/s13193-011-0078-2 · 2011 · External reference
Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer
10.1046/j.1365-2168.1999.01243.x · 1999 · External reference
A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection
10.1245/s10434-010-0981-8 · 2010 · External reference
Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial
10.1001/jama.2017.11470 · 2017 · External reference
Interplay between inflammation and cancer
10.1016/bs.apcsb.2019.09.004 · 2020 · External reference
Prediction of high nodal burden with ultrasound and magnetic resonance imaging in clinically node-negative breast cancer patients
10.1186/s40644-019-0191-y · 2019 · External reference
The research progress on the prognostic value of the common hematological parameters in peripheral venous blood in breast cancer
10.2147/ott.s227171 · 2020 · External reference
Prognostic role of preoperative circulating systemic inflammatory response markers in primary breast cancer: Meta-analysis
10.1093/bjs/znac319 · 2022 · External reference
Can inflammatory indices predict sentinel lymph node status in patients with early-stage breast cancer?
10.1097/md.0000000000034808 · 2023 · External reference
Diagnostic value of platelet/lymphocyte ratio (PLR) for predicting sentinel axillary lymph node positivity in early-stage breast cancer compared with ultrasonography
10.1111/ijcp.14939 · 2021 · External reference
Can neutrophil to lymphocyte ratio be a predictor tool for the non-sentinel lymph node metastasis in breast cancer?
10.21614/chirurgia.114.1.83 · 2019 · External reference
Peripheral blood inflammatory indexes in breast cancer: A review
10.1097/md.0000000000036315 · 2023 · External reference
Tumor associated macrophages and neutrophils in cancer
10.1016/j.imbio.2013.06.003 · 2013 · External reference
Cancer-related inflammation: Common themes and therapeutic opportunities
10.1016/j.semcancer.2011.12.005 · 2012 · External reference
Neutrophil/lymphocyte and platelet/lymphocyte ratios are not different among breast cancer subtypes
2017 · External reference
Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer
10.7314/apjcp.2014.15.10.4225 · 2014 · External reference
Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer
10.1038/bjc.2015.183 · 2015 · External reference
Polyphenol-rich diet is associated with decreased level of inflammatory biomarkers in breast cancer patients
10.32394/rpzh.2019.0068 · 2019 · External reference
Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy
10.1007/s12094-017-1732-0 · 2018 · External reference
Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients
10.1007/s12094-018-1999-9 · 2019 · External reference
